| Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study (NCT05491616) | Erasmus Medical Center | 2022-09-29 |
| Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia. (NCT05599243) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2022-09-29 |
| Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes. (NCT05909800) | Medical University of Warsaw | 2022-09-29 |
| A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET (NCT05482971) | PharmaEssentia | 2022-09-29 |
| Collagen-targeted PET Imaging for Early Interstitial Lung Disease (NCT05417776) | Massachusetts General Hospital | 2022-09-28 |
| Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR) (NCT05383209) | EyePoint Pharmaceuticals, Inc. | 2022-09-28 |
| ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL) (NCT05532722) | Abcuro, Inc. | 2022-09-28 |
| An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity (NCT05568953) | Singapore General Hospital | 2022-09-28 |
| Treatment of Pneumocystis in COPD (the TOPIC Study) (NCT05418777) | Corewell Health East | 2022-09-28 |
| Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia (NCT05487196) | Grace Lim, MD, MS | 2022-09-28 |
| Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer (NCT05456685) | AbbVie | 2022-09-28 |
| Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients (NCT05504083) | InventisBio Co., Ltd | 2022-09-28 |
| A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis (NCT05600036) | Alumis Inc | 2022-09-27 |
| Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer (NCT05509699) | Hutchison Medipharma Limited | 2022-09-27 |
| Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions (NCT05384691) | University of Leipzig | 2022-09-27 |
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP (NCT05667636) | Regina Elena Cancer Institute | 2022-09-27 |
| Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma (NCT05528952) | Centre Hospitalier Universitaire de Besancon | 2022-09-27 |
| Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer (NCT05725200) | Oslo University Hospital | 2022-09-27 |
| Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis (NCT05579899) | Evommune, Inc. | 2022-09-27 |
| Linezolid Dosing Strategies in Drug-Resistant TB (NCT05007821) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-27 |
| Phase II Dutasteride in Combination With CAB vs CAB in SDC (NCT05513365) | Radboud University Medical Center | 2022-09-27 |
| HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma (NCT06239532) | Qilu Hospital of Shandong University | 2022-09-27 |
| Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations (NCT05082025) | M.D. Anderson Cancer Center | 2022-09-27 |
| Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion (NCT05466149) | Allist Pharmaceuticals, Inc. | 2022-09-27 |
| Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma (NCT05427812) | Ichnos Sciences SA | 2022-09-27 |
| Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients (NCT05532696) | Anbogen Therapeutics, Inc. | 2022-09-27 |
| Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees. (NCT04839497) | Major Extremity Trauma Research Consortium | 2022-09-26 |
| Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer (NCT05679583) | Yonsei University | 2022-09-26 |
| First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation (NCT05548348) | Chongqing University Cancer Hospital | 2022-09-26 |
| Gallium-68 PSMA-11 PET in Participants With Prostate Cancer (NCT05034562) | M.D. Anderson Cancer Center | 2022-09-26 |
| Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers (NCT05608187) | Ilya Pharma | 2022-09-26 |
| A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment (NCT05516979) | SynAct Pharma Aps | 2022-09-26 |
| Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? (NCT05102396) | Samantha Rodrigues Camargo Neves de Moura | 2022-09-26 |
| A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. (NCT05375955) | Pfizer | 2022-09-26 |
| Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma (NCT05563012) | Renmin Hospital of Wuhan University | 2022-09-26 |
| A Study of Ponsegromab in People With Heart Failure (NCT05492500) | Pfizer | 2022-09-26 |
| A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05623982) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-09-26 |
| Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy (NCT05539287) | Tanta University | 2022-09-25 |
| Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events (NCT05476679) | Raziel Therapeutics Ltd. | 2022-09-25 |
| Assessment of Rituximab Therapeutic Response Versus Conventional Treatment (NCT05553496) | Ain Shams University | 2022-09-25 |
| Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma (NCT05535647) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-25 |
| Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease (NCT05540431) | Waleed Khaild Rahman Kareem Al-kabi | 2022-09-25 |
| Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS) (NCT05560152) | Ying Gao | 2022-09-25 |
| A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors (NCT05457517) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2022-09-24 |
| A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke (NCT05515393) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2022-09-24 |
| Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma. (NCT05472324) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-09-23 |
| A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (NCT05325866) | Amgen | 2022-09-23 |
| Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma (NCT05546827) | M.D. Anderson Cancer Center | 2022-09-23 |
| Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling (NCT04965064) | University of Rochester | 2022-09-23 |
| Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases. (NCT05542342) | Grupo Español Multidisciplinar de Melanoma | 2022-09-23 |
| A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy (NCT05464719) | M.D. Anderson Cancer Center | 2022-09-23 |
| Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma (NCT05039281) | M.D. Anderson Cancer Center | 2022-09-23 |
| A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease (NCT05607615) | Cyclo Therapeutics, Inc. | 2022-09-23 |
| Terazosin and Parkinson's Disease Extension Study (NCT05109364) | Cedars-Sinai Medical Center | 2022-09-23 |
| Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS (NCT05633407) | argenx | 2022-09-23 |
| RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT05405309) | University of Utah | 2022-09-23 |
| A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts (NCT05365035) | M.D. Anderson Cancer Center | 2022-09-23 |
| Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer (NCT05296512) | Elizabeth K. Lee MD | 2022-09-23 |
| Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients (NCT05443646) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-09-23 |
| Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT05327114) | Janssen Research & Development, LLC | 2022-09-23 |
| Enoxolone in Major Depression - Biomarker-outcome Relationship (NCT05570110) | Philipps University Marburg | 2022-09-23 |
| Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors (NCT05552729) | Yangzhou University | 2022-09-22 |
| Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome (NCT05322096) | Gedeon Richter Plc. | 2022-09-22 |
| Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study (NCT05445674) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2022-09-22 |
| QA102 Phase II Study in Subjects With Dry AMD (NCT05536752) | Smilebiotek Zhuhai Limited | 2022-09-22 |
| INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO (NCT05385159) | Assistance Publique Hopitaux De Marseille | 2022-09-22 |
| A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD (NCT05431088) | Pfizer | 2022-09-22 |
| A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER) (NCT05286619) | University of Malaya | 2022-09-22 |
| Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer (NCT05494580) | Sun Yat-sen University | 2022-09-22 |
| Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder (NCT05235919) | Holland Bloorview Kids Rehabilitation Hospital | 2022-09-22 |
| Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity (NCT03083431) | University of Zurich | 2022-09-22 |
| Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial (NCT05497804) | Mayo Clinic | 2022-09-22 |
| Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla (NCT05347212) | M.D. Anderson Cancer Center | 2022-09-22 |
| EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA (NCT05480228) | James P. Rathmell, MD | 2022-09-21 |
| A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer (NCT05394285) | Henan Cancer Hospital | 2022-09-21 |
| Efficacy of VTP-300 in Chronic Hepatitis B Infection (NCT05343481) | Barinthus Biotherapeutics | 2022-09-21 |
| A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia (NCT05579691) | Larimar Therapeutics, Inc. | 2022-09-21 |
| Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers (NCT05121051) | National Cancer Institute (NCI) | 2022-09-21 |
| EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy (NCT05476276) | James P. Rathmell, MD | 2022-09-21 |
| PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 (NCT05543707) | Pardes Biosciences, Inc. | 2022-09-21 |
| Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS (NCT05981742) | Al-Rasheed University College | 2022-09-21 |
| Zinc and Green Tea Extract for Community Respiratory Viral Infections (NCT04898023) | University of Missouri-Columbia | 2022-09-21 |
| Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes (NCT05153070) | Assistance Publique - Hôpitaux de Paris | 2022-09-21 |
| Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age (NCT05590884) | Guerbet | 2022-09-21 |
| CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma (NCT05440786) | Eli Lilly and Company | 2022-09-20 |
| Clinical Application of Stem Cell Educator Therapy in Alopecia Areata (NCT04011748) | Throne Biotechnologies Inc. | 2022-09-20 |
| Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003） (NCT05512520) | Sun Yat-sen University | 2022-09-20 |
| Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors (NCT05450562) | Sanofi | 2022-09-20 |
| Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes (NCT04011020) | Throne Biotechnologies Inc. | 2022-09-20 |
| A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors (NCT05508659) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-09-20 |
| A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases (NCT05048212) | M.D. Anderson Cancer Center | 2022-09-20 |
| Capsaicin for Cerebral Perfusion Augmentation (NCT05543837) | Instituto Mexicano del Seguro Social | 2022-09-20 |
| Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer (NCT05545436) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-09-20 |
| RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2 (NCT05403242) | Chinese PLA General Hospital | 2022-09-20 |
| Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma (NCT05552651) | Tao Jiang | 2022-09-20 |
| Silver Nitrate Versus Topical Steroid For Umbilical Granuloma (NCT06363539) | Children Hospital and Institute of Child Health, Lahore | 2022-09-20 |
| Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma (NCT05109052) | University of Rochester | 2022-09-20 |
| Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis (NCT03887273) | Q Therapeutics, Inc. | 2022-09-20 |
| Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy) (NCT05480449) | Stephan Grupp MD PhD | 2022-09-20 |
| Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer (NCT05730673) | CytoDyn, Inc. | 2022-09-20 |